Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry

NCT06395402 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT06395402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06395402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
Lead sponsor
University of Iowa
Phase
Phase 2
Overall status
Recruiting
Start date
May 3, 2024
Completion date
December 31, 2029
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumor grade 1, neuroendocrine tumor grade 2, neuroendocrine tumors